248700])
, [12] [13] [14] distal arthrogryposis type 5 (DA5 [MIM 108145]), 13, 14 and Schwartz-Jampel (MIM 255800). 13 Furthermore, in the absence of cleft palate, GS can be virtually indistinguishable from distal arthrogryposis type 1 (DA1 [MIM 108120]) and distal arthrogryposis type 2B (DA2B [MIM 601680]). Accordingly, Bamshad et al. categorized GS as distal arthrogryposis type 3 (DA3) in the revised classification of distal arthrogryposis (DA) syndromes but questioned whether GS was an etiologically distinct syndrome. 7 In an effort to ascertain GS cases for gene-mutationdiscovery studies, we reviewed phenotypic data from 170 families affected by DA1, DA2B, DA3, or DA5 of unknown genetic etiology and identified 12 families affected by a phenotype consistent with GS ( Figure 1 ; Table 1 ; Figure S1 , available online). At least one affected individual in each of these GS-affected families had cleft palate and congenital contractures affecting both the hands and feet. All studies were approved by the institutional review boards of the University of Washington and Seattle Children's Hospital, and informed consent was obtained from participants or their parents. To identify causative mutations for GS, we first used Sanger sequencing to screen the proband of each GS-affected family for mutations in genes including TPM2 (MIM 190990), TNNT3 (MIM 600692), TNNI2 (MIM 191043) , and MYH3 (MIM 160720), known to associate with DA1 or DA2B. We also screened CHRNG (MIM 100730), mutations in which cause congenital contractures in Escobar syndrome (MIM 265000). Table 1 , which includes a detailed description of the phenotype of each affected individual. Figure S1 provides a pedigree of each GS-affected family, and Figure S3 provides a pedigree of the MWS-affected family (II). 
This table provides a summary of clinical features of affected individuals from families in which PIEZO2 mutations were identified. Clinical characteristics listed in the table are primarily features that distinguish the different diagnoses (GS, DA5, and MWS). In addition to showing the characteristics listed in the table, affected individuals had contractures of the hands and feet, which are characteristic of DA disorders. Abbreviations are as follows: þ, presence of a finding; À, absence of a finding; þ/À, possible or very mild features; BL, bilateral; BU, bifid uvula; CP, cleft palate; ND, no data available; NT, not tested; ROM, range of motion; and x, described as Brown syndrome.
Next, we selected five GS-affected families in which the affected individual had facial characteristics similar to those of affected individuals from GS-affected families in which vertical transmission of GS was evident. Each GS proband was screened for copy-number variations (CNVs) by array comparative genomic hybridization on the Illumina HumanCytoSNP-12. No pathogenic mutations or shared CNV regions were identified. Next, exome sequencing was performed on four GS parent-child trios (three simplex cases [from families B-D] and one family with an affected mother and son [family A]) and a single affected individual (from family E) ( Figure 1 ; Figure S1 ).
In brief, 1 mg of genomic DNA was subjected to a series of shotgun-library-construction steps, including fragmentation through acoustic sonication (Covaris), end polishing ( Demultiplexed BAM files were aligned to the human reference genome (hg19, UCSC Genome Browser) with the Burrows-Wheeler Aligner (BWA). 22 Read data from a flow-cell lane were treated independently for alignment and quality-control purposes in instances where the merging of data from multiple lanes was required. All aligned read data were subjected to (1) removal of duplicate reads (Picard), (2) indel realignment by the Genome Analysis Toolkit (GATK) IndelRealigner, and (3) base-quality recalibration by the GATK TableRecalibration. Variant detection and genotyping were performed with the UnifiedGenotyper tool from GATK (v.1.529). Variant data for each sample were formatted (variant call format) as ''raw'' calls that contained individual genotype data for one or multiple samples and were flagged with the filtration walker (GATK) for marking sites that were of lower quality and potential false positives (e.g., quality scores % 50, allelic imbalance R 0.75, long homopolymer runs > 3, and/or low quality by depth < 5). Variants were annotated with SeattleSeq Annotation 134, and variants with an alternative allele frequency > 0.01 in the NHLBI Exome Sequencing Project Exome Variant Server (ESP6500) or 1000 Genomes Project 23 or > 0.2 in an internal database derived from other University of Washington Center for Mendelian Genomics exomes were excluded prior to analysis. Additionally, intergenic variants or variants that were flagged as low quality or potential false positives (quality scores % 30, long homopolymer runs > 5, low quality by depth < 5, within a cluster of SNPs) were also excluded from analysis. Variants that were only flagged by a strand bias (strand bias R 0.10) or allele-balance filter (allelic imbalance R 0.75) were included in further analyses because both flags have previously been found to be applied to valid pathogenic variants. CNV calls were also generated from exome data with CoNIFER. 24 Analysis of variants from exome sequencing under a model matching the predicted pattern of inheritance (autosomal dominant in family A and de novo in families B-E; Figure S1 ) identified mutations in a single gene, piezotype mechanosensitive ion channel component 2 (PIEZO2 [MIM 613629; RefSeq accession number NM_022068.2]), in all five GS-affected families. Specifically, in four families (A and C-E), a recurrent missense mutation (c.8057G>A) predicted to cause a nonconservative arginine-to-histidine substitution (p.Arg2686His) was found in each family. An 8 bp deletion (c.8238_8245del8) predicted to result in an immediate stop codon (p.Trp2746*) was found to be de novo in a single trio (family B). Neither mutation was found in ESP6500, the 1000 Genomes Project (phase 1 release), 23 or internal databases (>1,400 chromosomes).
Sanger sequencing confirmed each variant identified. In families C-E, the c.8057G>A mutation was found to have arisen de novo. In family A, c.8057G>A was transmitted from an affected mother to her affected offspring, and Sanger sequencing confirmed that the two other affected individuals in family A also carried the c.8057G>A mutation. To determine the extent to which mutations in PIEZO2 cause GS, we used molecular inversion probes (MIP) 25, 26 for targeted sequencing of PIEZO2 in seven additional GS-affected families. MIPs can be used for multiplex targeted sequence capture, followed by massively parallel sequencing of capture products. This strategy is efficient and cost effective for sequencing large genes, such as the 52-exon gene PIEZO2, in modest to large sample sets. Pooled and phosphorylated MIP probes targeting 8,259 bp of PIEZO2 coding sequence plus 20 bp of intron-exon flanking regions were designed 10 and used in capture reactions with 100 ng of genomic DNA from each individual. PCR was performed with universal primers, and unique 8-base sample indexes were introduced on the tagged reverse primer. The individual samples were then pooled, and the resulting library was purified with magnetic beads (Agencourt AMPure XP). After Picogreen quantification for determining the appropriate dilution, the library was sequenced on an Illumina MiSeq system. The alignment (BWA v.0.5.9-r16), analysis (GenomeAnalysisTK-2.3-4-g57ea19f.), and filtering (SeattleSeq Annotation 137) of the variants were similar to the filtering of exome variants in that candidate nonsynonymous, nonsense, and deletion and/or duplication coding variants or splicing variants that were not seen in variant databases were chosen for further confirmation by Sanger sequencing. MIP sequencing of PIEZO2 and variant confirmation in probands and family members by Sanger sequencing identified the same missense mutation (c.8057G>A [p.Arg2686His]) in PIEZO2 in five additional families affected by GS. Altogether, mutations in PIEZO2 were found in 10 of 12 GS-affected families, and nine of ten families shared the same missense mutation. All ten mutations occurred in exon 52 ( Figure 2 ). Mutations in PIEZO2 have recently been reported to cause congenital contractures and ophthalmoplegia in two families affected by DA5. 27 Accordingly, the observation that the phenotypic characteristics of GS and DA5 overlap is consistent with the discovery that mutations in PIEZO2 also cause GS. Indeed, among the 15 GSaffected individuals (from ten families) in whom we found PIEZO2 mutations, five also had ptosis and two had ophthalmoplegia.
To further explore the genetic and phenotypic overlap with DA5, we used a combination of MIP and Sanger sequencing to screen PIEZO2 in 29 families affected by DA5. Mutations in PIEZO2 were found in 24/29 (83%) DA5-affected families (Tables 1 and 2 ; Figure 2 ; Figures S2 and S5), including 14/16 (88%) familial cases and 10/13 (77%) simplex cases. Forty-two percent (10/24) of DA5-affected families had the same recurrent c.8181_8183delAGA (p.Glu2727del) mutation (Table 2 ). In one DA5-affected family (family Z, Figure S2 ), the c.8181_8183delAGA mutation found in the proband was also detected at a low level (11%) in a DNA sample obtained from peripheral blood in his unaffected father ( Figure S4 ). The presence of this mutation was confirmed in DNA sampled from both buccal cells (10%) and saliva (12%). This observation suggests that either the penetrance of c.8181_8183delAGA was incomplete and/ or the level of mosaicism in the father was too low to cause the phenotypic characteristics of DA5. Two simplex cases of DA5 (in families X and Y, Figure S2 ) had a recurrent c.8057G>A (p.Arg2686His) mutation, the same one found to cause GS ( Table 2) . Neither individual had a cleft palate.
GS and DA5 are phenotypically similar to MWS, a rare disorder for which the genetic basis has not yet been discovered. MWS has been hypothesized to be etiologically related to both DA 12, 28 and GS. 14 Therefore, we hypothesized that mutations in PIEZO2 might also cause MWS. MWS is characterized by joint contractures including camptodactyly, cleft palate, blepharophimosis, ''immobile facies,'' diminished muscular bulk, developmental delay, and hindbrain malformations, most commonly DandyWalker malformation. The latter is notable because hindbrain malformations were found in several individuals with PIEZO2 mutations and either GS or DA5. Specifically, three of the families affected by GS had a Chiari I malformation, and one individual with DA5 had a Dandy-Walker malformation. Sequencing of PIEZO2 in two cases of MWS revealed a de novo c.8056C>T (p.Arg2686Cys) mutation in one family. Whereas this mutation is predicted to cause a cysteine substitution in MWS, mutation of the adjacent nucleotide (c.8057G>A) is predicted to cause a histidine substitution for the same arginine in amino acid position 2686 (p.Arg2686His) in GS and DA5 (Table 2) . Collectively, we identified 13 different mutations in PIEZO2 (Figure 2 ; Table 2 ) in 35 families affected by GS (n ¼ 10), DA5 (n ¼ 24), or MWS (n ¼ 1). Ten of these mutations are missense, two are predicted to cause a frameshift, and one is a 3 bp in-frame deletion (Table 2) . Recurrent mutations occurred at five sites, and two of these (c.8057G>A [p.Arg2686His] and c.8181_8183delAGA [p.Glu2727del]) were observed in ten or more families and arose de novo (six missense and three deletions) in nine of these families. Although the sample size is small, these sites could represent mutation hotspots in PIEZO2.
The phenotypes of GS, DA5, and MWS are distinguished from one another by just a few major characteristics. However, some individuals with mutations in PIEZO2 had characteristics that spanned more than one of these diagnoses (Figure 3) . Furthermore, the c.8057G>A (p.Arg2686His) mutation, which explains most of the GS cases, was found in two DA5-affected families (i.e., families X and Y). This observation raises the question as to whether GS, DA5, and MWS are distinct syndromes or different manifestations of the same condition. One explanation for the overlap of clinical phenotypes among these syndromes is that there is a strong genotype-phenotype relationship between PIEZO2 mutations and the major characteristics that vary among GS, DA5, and MWS. Accordingly, we tested whether c.8181_8183de-lAGA and c.8057G>A were associated with the presence of cleft palate, pulmonary disease, ophthalmoplegia, scoliosis, or cerebellar malformation regardless of diagnosis. Cleft palate was significantly associated (Fisher's exact test, adjusted p value < 0.0001) with c.8057G>A, but no other associations were significant. All of the individuals with GS and a c.8057G>A mutation had either cleft palate (n ¼ 12) or a bifid uvula (n ¼ 2), but only four were reported to have ptosis and only one had ophthalmoplegia. These findings suggest that the phenotype caused by c.8057G>A is a distinct entity, namely GS. Yet, neither of the individuals with the c.8057G>A mutation in the two DA5-affected families had cleft palate or a bifid uvula. Given the reduced penetrance of cleft palate in GS, we suspect that the correct diagnosis in these two families is GS rather than DA5.
Eighty-five percent (11/13) of the mutations we identified in PIEZO2 are predicted to alter amino acids in the intracellular C-terminal domain of PIEZO2. The C-terminal domain is highly conserved across metazoans, although its function is unknown. Nevertheless, its integrity appears to be vital to the function of PIEZO2 in normal physiology and development of skeletal muscle. Moreover, at least two PIEZO2 regions that encode the C-terminal domain (c.8057G and c.8181_8183delAGA) appear to be hotspots for mutations, more intolerant of variation, or some combination thereof.
PIEZO2 and PIEZO1 are large, transmembrane protein components of mechanically or stretch-activated ion channels found in many tissues. 29 Recent electrophysiological studies of two individuals with DA5 have revealed that c.8181_8183delAGA (p.Glu2727 del) is a gain-offunction mutation that causes PIEZO2-dependent, mechanically activated currents to inactivate slower but recover faster from this inactivation. As a result, altered channels transduce repetitive mechanical signals more efficiently. 27 One of the more unusual clinical characteristics of individuals with DA5 is that their muscles, particularly the muscles of the anterior chest wall, feel firm or ''woody'' on palpation, suggesting that resting muscle tone might be higher. Additionally, some individuals with DA5 develop progressive pulmonary insufficiency partly because of restrictive chest disease. Furthermore, in contrast to other DA disorders, the contractures of some individuals with DA5 appear to worsen with age despite intervention (e.g., physical therapy). Collectively, these observations suggest that in addition to affecting the development of skeletal muscle, dysregulated mechanotransduction due to PIEZO2 mutations might also affect the function of skeletal muscles after birth. The absence of a PIEZO2 mutation in two GS individuals and one MWS individual suggests that both could be genetically heterogeneous. However, it is likely that that our sequencing strategy using MIPs could not reliably detect some indels, including single-exon deletions. To assess whether deletions or duplications that include PIEZO2 might indeed be responsible for some cases of GS or MWS, we queried the DECIPHER database and identified 44 individuals with either deletions (n ¼ 22) or duplications (n ¼ 22) over the region containing all or part of PIEZO2. For the 30 of these individuals for whom phenotypic information was available, ten had a feature that could be considered to be within the GS and DA5 phenotype spectrum. Specifically, seven had some type of congenital contracture, three had cleft palate, and two had ptosis. Only two of these ten individuals had more than one of these characteristics. None of the individuals with the smallest deletions that included PIEZO2 had any of these features. This observation is consistent with the findings of Coste et al., who reported that DA5 is caused by gain-of-function, rather than loss-of-function, mutations in PIEZO2. 27 The hypothesis that the DA5 phenotype in individuals with PIEZO2 mutations might reflect ion channel hyperresponsiveness to forces engendered during development and later during postnatal life 27 tems, including the CNS. In the brain, for example, mechanical interaction between cells and their environment affects the speed and directionality of neuronal migration. 30 How mechanical forces are sensed and transduced by such cells is unclear. PIEZO2 is expressed in the brain, including the hindbrain, but there is virtually no information available about its role, if any, in the development of the CNS. The observation that some individuals with GS, DA5, or MWS and PIEZO2 mutations have hindbrain malformations offers perhaps a window for further investigation. In summary, we used exome sequencing to discover that mutations in PIEZO2 cause GS and MWS. Furthermore, we found that mutations in PIEZO2 also explain the overwhelming majority of cases of DA5. The genetic and phenotypic overlap among these three conditions supports a shared developmental mechanism, although the presence of a genotype-phenotype relationship in GS suggests that certain functions of PIEZO2 might be perturbed by the disruption of specific residues or domains. Along with our recent report that mutations in ECEL1 (MIM 605896) cause distal arthrogryposis type 5D 31 (DA5D [MIM 615065]), the present study suggests that DA5 and its subtypes are caused by a disturbance of the neuromuscular pathways that influence the development of skeletal muscle, whereas other DA types are caused by mutations in genes that encode proteins of the contractile apparatus. Although DA5 and its subtypes appear to be phenotypically distinct from other DAs, particularly the much more common DA1 and DA2B, 32 distinguishing DA5 from other DAs in a clinical setting is often challenging. Accordingly, the existing heuristic classification of DAs appears to be a helpful tool for prioritizing the differential diagnosis. Yet, because natural history varies widely among different DA disorders, including between DA5D and DA5, identification of the underlying causal variant is essential.
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